Your browser doesn't support javascript.
loading
Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared with 2-dose BNT162b2 vaccination in kidney transplant recipients.
Benning, Louise; Morath, Christian; Bartenschlager, Marie; Reineke, Marvin; Töllner, Maximilian; Nusshag, Christian; Kälble, Florian; Reichel, Paula; Schaier, Matthias; Schnitzler, Paul; Zeier, Martin; Süsal, Caner; Bartenschlager, Ralf; Speer, Claudius.
Afiliación
  • Benning L; Department of Nephrology, University of Heidelberg, Heidelberg, Germany. Electronic address: louise.benning@med.uni-heidelberg.de.
  • Morath C; Department of Nephrology, University of Heidelberg, Heidelberg, Germany.
  • Bartenschlager M; Department of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany.
  • Reineke M; Department of Nephrology, University of Heidelberg, Heidelberg, Germany.
  • Töllner M; Department of Nephrology, University of Heidelberg, Heidelberg, Germany.
  • Nusshag C; Department of Nephrology, University of Heidelberg, Heidelberg, Germany.
  • Kälble F; Department of Nephrology, University of Heidelberg, Heidelberg, Germany.
  • Reichel P; Department of Nephrology, University of Heidelberg, Heidelberg, Germany.
  • Schaier M; Department of Nephrology, University of Heidelberg, Heidelberg, Germany.
  • Schnitzler P; Department of Virology, University of Heidelberg, Heidelberg, Germany.
  • Zeier M; Department of Nephrology, University of Heidelberg, Heidelberg, Germany.
  • Süsal C; Institute of Immunology, University of Heidelberg, Heidelberg, Germany; Transplant Immunology Research Center of Excellence, Koç University Hospital, Istanbul, Turkey.
  • Bartenschlager R; Department of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany; German Center for Infection Research, Partner Site Heidelberg, Heidelberg, Germany; Division Virus-Associated Carcinogenesis, German Cancer Research Center, Heidelberg, Germany.
  • Speer C; Department of Nephrology, University of Heidelberg, Heidelberg, Germany; Department of Molecular Medicine Partnership Unit Heidelberg, European Molecular Biology Laboratory, Heidelberg, Germany.
Kidney Int ; 101(3): 639-642, 2022 03.
Article en En | MEDLINE | ID: mdl-34954213

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Riñón / COVID-19 / Vacuna BNT162 Límite: Humans Idioma: En Revista: Kidney Int Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Riñón / COVID-19 / Vacuna BNT162 Límite: Humans Idioma: En Revista: Kidney Int Año: 2022 Tipo del documento: Article